From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Results: DCTA

Search articles by EPIC code
EPIC DCTA
views

Directa Plus – 2021 results, how “comfortable” with forecasts?...

Producer and supplier of graphene nanoplatelets-based products Directa Plus (DCTA) has announced 2021 results emphasising “revenue and profitability which have exceeded consensus market expectations” and “a number of exciting opportunities in our targeted markets”. So what of a current 121.5p share price?...

EPIC DCTA
views

Directa Plus – patent grant, a step towards addressing a large global market?

Self-styled “a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets”, Directa Plus (DCTA) has announced it “has been granted an EU-wide patent covering the use of its G+® graphene in golf ball applications”. It emphasises this “the first step towards addressing a very large global market” and the shares have responded currently 4% higher to 106p, a £65 million market capitalisation. Is this justified?...

EPIC DCTA
views

Directa Plus – trading update argues “a strong pipeline of opportunities”. It looks to need them...

Self-styled “a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets” Directa Plus (DCTA) has made a trading update including noting 2020 revenue “further improvement” from previously reported expectations, Q1 2021 revenue expected to be up 20% from the same period last year and that “there is a strong pipeline of opportunities”. Why are the shares though still well down from 145p reached earlier this year?...

Page 2 of 4 (32 articles)
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Complete Coverage

Recent Comments